Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2011; 136(21): 1123-1127
DOI: 10.1055/s-0031-1280522
DOI: 10.1055/s-0031-1280522
Prinzip & Perspektive | Review article
Diabetologie© Georg Thieme Verlag KG Stuttgart · New York
Die Rolle der Betazelle im Diabetes mellitus
The beta cell in diabetesFurther Information
Publication History
eingereicht: 11.1.2011
akzeptiert: 17.3.2011
Publication Date:
17 May 2011 (online)

Schlüsselwörter
Betazellen des Pankreas - Typ-1-Diabetes - Typ-2-Diabetes - Therapie
Keywords
beta cells - diabetes type 1 - diabetes type 2 - treatment
Literatur
- 1
Bluestone J A, Auchincloss H, Nepom G T. et al .
The Immune Tolerance Network
at 10 years: tolerance research at the bedside.
Nat Rev
Immunol.
2010;
10
797-803
MissingFormLabel
- 2
Cnop M, Welsh N, Jonas J C. et al .
Mechanisms of pancreatic beta-cell death
in type 1 and type 2 diabetes: many differences, few similarities.
Diabetes.
2005;
54
(Suppl
2)
S97-107
MissingFormLabel
- 3 Eisenbarth G S. Type 1 diabetes. Molecular, cellular and
clinical immunology. Book. Online Edition version 3.0
ed;. http://www.barbaradaviscenter.org/ 2010
MissingFormLabel
- 4
Eizirik D L, Colli M L, Ortis F.
The role of inflammation in insulitis and beta-cell loss in
type 1 diabetes.
Nature reviews.
2009;
5
219-226
MissingFormLabel
- 5
Elsner M, Gehrmann W, Lenzen S.
Peroxisome-generated hydrogen peroxide as important mediator
of lipotoxicity in insulin-producing cells.
Diabetes.
2011;
60
200-218
MissingFormLabel
- 6
Gehrmann W, Elsner M, Lenzen S.
Role of metabolically generated reactive oxygen species for
lipotoxicity in pancreatic beta-cells.
Diabetes, obesity & metabolism.
2010;
12
(Suppl 2)
149-158
MissingFormLabel
- 7
Gurgul E, Lortz S, Tiedge M, Jörns A, Lenzen S.
Mitochondrial
catalase overexpression protects insulin-producing cells against
toxicity of reactive oxygen species and proinflammatory cytokines.
Diabetes.
2004;
53
2271-2280
MissingFormLabel
- 8
Jörns A, Günther A, Hedrich H J. et al .
Immune cell infiltration,
cytokine expression, and beta-cell apoptosis during the development
of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm
rat.
Diabetes.
2005;
54
2041-2052
MissingFormLabel
- 9
Leahy J L, Hirsch I B, Peterson K A, Schneider D.
Targeting
beta-cell function early in the course of therapy for type 2 diabetes
mellitus.
The Journal of clinical endocrinology and metabolism.
2010;
95
4206-4216
MissingFormLabel
- 10
Lenzen S.
Oxidative stress: the vulnerable beta-cell.
Biochemical
Society transactions.
2008;
36
343-347
MissingFormLabel
- 11
Rahier J, Guiot Y, Goebbels R M, Sempoux C, Henquin J C.
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
Diabetes, obesity & metabolism.
2008;
10
(Suppl 4)
32-42
MissingFormLabel
- 12
Schloot N C.
Immunintervention zum Betazellerhalt bei Typ-1-Diabetes.
Dtsch
Med Wochenschr.
2010;
135
915-921
MissingFormLabel
- 13
Tiedge M, Lortz S, Drinkgern J, Lenzen S.
Relation between antioxidant enzyme
gene expression and antioxidative defense status of insulin-producing
cells.
Diabetes.
1997;
46
1733-1742
MissingFormLabel
- 14 Waldhäusl W, Lenzen S S. Kapitel 14. Kohlenhydratstoffwechsel. In: Schwarz S, Förster O, Peterlik M, Schauenstein K, Wick G, ed. Pathophysiologie – Molekulare, zelluläre,
systemische Grundlagen von Erkrankungen.. Wien: Wilhelm
Maudrich Verlag; 2007
MissingFormLabel
Prof. Dr. med. Sigurd Lenzen
Institut für Klinische Biochemie
Medizinische
Hochschule Hannover
Carl-Neuberg-Str. 1
30625
Hannover
Phone: 0511/532-6525
Fax: 0511/532-3584
Email: lenzen.sigurd@mh-hannover.de